%0 Journal Article
%T Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer
%A A. John Iafrate
%A Aditya Bardia
%A Andrzej Niemierko
%A Arielle J. Medford
%A Ben S. Wittner
%A Benjamin Wesley
%A Beverly Moy
%A Brittany A. Reeves
%A Daniel A. Haber
%A Dejan Juric
%A Giuliana Malvarosa
%A Jeffrey Peppercorn
%A Joseph A. LiCausi
%A Laura Spring
%A Leif Ellisen
%A Megan Yuen
%A Mehmet Toner
%A Michael S. Lawrence
%A Neelima Vidula
%A Shyamala Maheswaran
%A Steven Isakoff
%A Taronish D. Dubash
%J Archive of "NPJ Precision Oncology".
%D 2019
%R 10.1038/s41698-019-0090-5
%X Comparison of the clinical characteristics among patients with HER2-mutant versus HER2 wild type, metastatic HR+/HER2£¿ breast cance
%K Breast cancer
%K Cancer genomics
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635494/